Oncoinvent ASA
ONCIN
Rank in Stocks
#27387
Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to... Oncoinvent ASA, a clinical-stage firm based in Oslo, Norway, is dedicated to developing innovative radiopharmaceutical treatments for various cancers. Its primary therapeutic agent is Radspherin, an alpha-emitting radiotherapeutic, which is currently undergoing investigation in two Phase 1/2a and one randomized Phase 2 clinical trials. This promising candidate is designed to target and treat malignancies that have metastasized to body cavities, specifically including the peritoneum.
Share Price
$7.17
Market Cap
$32.11M
Change (1 day)
0.29%
Change (1 year)
6,402.12%
Country
NO
Trade Oncoinvent ASA (ONCIN)
Category
Healthcare
Dividend history for Oncoinvent ASA (ONCIN)
Oncoinvent ASA (stock symbol: ONCIN) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for Oncoinvent ASA (ONCIN) from 2026 to 2026
Annual dividend payments
| Year | Dividend (stock split adjusted) | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
List of all dividend payments
| Year | Dividend | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
Dividend payments for similar companies or competitors
| Company | Number of dividend payments | Country |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 64.00% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
